Cytokines and uveitis, a review

References

• Trotta P. P. Cytokines: an overview. Am. J. Reprod. Immunol. 1991; 25: 137–141
   Google Scholar
• Balkwill F. R., Burke F. The cytokine network. Immunol. Today 1989; 10: 299–304
   PubMedGoogle Scholar
• Chandler J. W., Heise E. R., Weiser R. S. Induction of delayed-type sensitivity-like reactions in the eye by the injection of lymphokines. Invest. Ophthalmol. 1973; 12: 400–409
   Google Scholar
• Stoner G. L., Brosnan C. F., Wisniewski H. M., Bloom B. R. Studies on demyelination by activated lymphocytes: 1. Effects of a mononuclear cell infiltrate induced by products of activated lymphocytes. J. Immunol. 1977; 118: 2094–2102
   Google Scholar
• Lui S. H., Prendergast R. A., Silverstein A. M. The role of lymphokines in immunogenic uveitis. Invest. Ophthalmol. Vis. Sci. 1983; 24: 361–367
   Google Scholar
• Beutler B., Cerami A. The biology of cachectin/TNF: a primary mediator of the host response. Ann. Rev. Immunol. 1989; 7: 625–655
   PubMed Web of Science ®Google Scholar
• Fong Y., Lowry S. F. Tumor necrosis factor in the pathophysiology of infection and sepsis. Clin. Immunol. Immunopathol. 1990; 55: 157–170
   PubMedGoogle Scholar
• Femandez-Botran R. Soluble cytokine receptors: their role in immunoregulation. FASEB J. 1991; 5: 2567–2574
   Google Scholar
• Kulkarni P. S., Srinivasan B. D. Cachectin: a novel polypeptide induces uveitis in the rabbit eye. Exp. Eye Res. 1988; 46: 631–633
   PubMed Web of Science ®Google Scholar
• Rosenbaum J. T., Howes E. L., Rubin R. M., Samples J. R. Ocular inflammatory effects of intravitreally injected tumor necrosis factor. Am. J. Pathol. 1988; 133: 47–53
   PubMed Web of Science ®Google Scholar
• Fleisher L. N., Ferrell J. B., McGahan M. C. Ocular inflammatory effects of intravitreally injected tumor necrosis factor-alpha and endotoxin. Inflammation 1990; 14: 325–335
   PubMed Web of Science ®Google Scholar
• Fleisher L. N., Ferrell J. B., Smith M. G., McGahan M. C. Lipid mediators of tumour necrosis factor-a-induced uveitis. Invest. Ophthalmol. Vis. Sci. 1991; 32: 2393–2399
   PubMed Web of Science ®Google Scholar
• Brosnan C. F., Litwak M. S., Schroeder C. E., Selmaj K., Raine C. S., Arezzo J. C. Preliminary studies of cytokine-induced functional effects on the visual pathways in the rabbit. J. Neuroimmunol. 1989; 25: 227–239
   Google Scholar
• Di Giovine F. S., Duff G. W. Interleukin 1: the first interleukin. Immunol. Today 1990; 11: 13–20
   PubMedGoogle Scholar
• Roberge F. G., Caspi R. R., Nussenblatt R. B. Glial retinal Miiller cells produce IL-1 activity and have a dual effect on autoimmune T helper lymphocytes: antigen presentation manifested after removal of suppressive activity. J. Immunol. 1988; 140: 2193–2196
   PubMed Web of Science ®Google Scholar
• Grabner G., Luger T. A., Luger B. M., Smolin G., Oh J. O. Biological properties of the thymocyte-activating factor (CETAF) produced by a corneal cell line (SIRC). Invest. Ophthalmol. Vis. Sci. 1983; 24: 589–595
   Google Scholar
• Shams N. B.K., Sigel M. M., Davis M. Interferon-?, Staphylococcus aureus, and lipopolysaccharide/silica enhance interleukin-1β production by human corneal cells. Reg. Immunol. 1989; 2: 136–148
   PubMedGoogle Scholar
• Niederkorn J. Y., Peeler J. S., Mellon J. Phagocytosis of particulate antigens by corneal epithelial cells stimulates interleukin-1 secretion and migration of Langerhans cells into the central cornea. Reg. Immunol. 1989; 2: 387–417
   Google Scholar
• Helbig H., Kittredge K. L., Gurley R. C., Thurau S. R., Palestine A. G., Nussenblatt R. B. Endotoxin-induced production of inflammatory mediators by cultured ciliary epithelial cells. Curr. Eye Res. 1990; 2: 501–505
   Google Scholar
• Rosenbaum J. T., Samples J. R., Hefeneider S. H., Howes E. L. Ocular inflammatory effects of intravitreal interleukin 1. Arch. Ophthalmol. 1987; 105: 1117–1120
   PubMed Web of Science ®Google Scholar
• Rubin R. M., Rosenbaum J. T. A platelet-activating factor antagonist inhibits interleukin 1-induced inflammation. Biochem. Biophys. Res. Commun. 1988; 154: 429–436
   PubMedGoogle Scholar
• Ferrick M. R., Thurau S. R., Oppenheim M. H., Herbort C. R., Ni M., Zachariae C. O.C., Matsushima K., Chan C. C. Ocular inflammation stimulated by intravitreal interleukin-8 and interleukin-1. Invest. Ophthalmol. Vis. Sci. 1991; 32: 1534–1539
   PubMed Web of Science ®Google Scholar
• Bhattacherjee P., Henderson B. Inflammatory responses to intraocularly injected interleukin 1. Curr. Eye Res. 1987; 6: 929–934
   PubMed Web of Science ®Google Scholar
• Martiney J. A., Litwak M., Berman J. W., Arezzo J. C., Brosnan C. F. Pathophysiologic effect of interleukin-lb in the rabbit retina. Am. J. Pathol. 1990; 137: 1411–1423
   PubMed Web of Science ®Google Scholar
• Dawson M. M. Interleukin-2. “Lymphokines and Interleukins”, M. M. Dawson. Open University Press, BuckinghamEngland 1991; 106–128
   Google Scholar
• Hooks J. J., Chan C. C., Detrick B. Identification of the lymphokines, interferon-gamma and interleukin-2, in inflammatory eye diseases. Invest. Ophthalmol. Vis. Sci. 1988; 29: 1444–1451
   PubMed Web of Science ®Google Scholar
• Mondino B. J., Sidikaro Y., Mayer F. J., Sumner H. L. Inflammatory mediators in the vitreous humor of AIDS patients with retinitis. Invest. Ophthalmol. Vis. Sci. 1990; 31: 798–804
   PubMedGoogle Scholar
• Arocker-Mettinger E., Asenbauer T., Ulbrich S., Grabner G. Serum interleukin 2-receptor levels in uveitis. Curr. Eye Res. 1990; 9: 25–29, Suppl
   PubMed Web of Science ®Google Scholar
• Deschenes J., Char H. D., Kaleta S. Activated T lymphocytes in uveitis. Br. J. Ophthalmol. 1988; 72: 83–87
   PubMed Web of Science ®Google Scholar
• Akira S., Hirano T., Taga T., Kishimoto T. Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF). FASEB J. 1990; 4: 2860–2867
   PubMed Web of Science ®Google Scholar
• Hirano T., Akira S., Taga T., Kishimoto T. Biological and clinical aspects of interleukin 6. Immunol. Today 1990; 11: 443–449
   PubMedGoogle Scholar
• Novick D., Engelmann H., Wallach D., Rubinstein M. Soluble cytokine receptors are present in normal human urine. J. Exp. Med. 1989; 170: 1409–1414
   PubMed Web of Science ®Google Scholar
• Malecaze F., Chollet P., Cavrois E., Vita N., Arné J. L., Ferrara P. Role of interleukin 6 in the inflammatory response after cataract surgery, an experimental and clinical study. Arch. Ophthalmol. 1991; 109: 1681–1683
   PubMedGoogle Scholar
• Hoekzema R., Murray P. I., Kijlstra A. Cytokines and intraocular inflammation. Curr. Eye. Res. 1990; 9: 207–211, Supply)
   PubMed Web of Science ®Google Scholar
• Hoekzema R., Murray P. I., Van Haren M. A.C., Helle M., Kijlstra A. Analysis of interleukin-6 in endotoxin-induced uveitis. Invest. Ophthalmol. Vis. Sci. 1991; 32: 88–95
   PubMed Web of Science ®Google Scholar
• Hoekzema R., Verhagen K., Van Haren M. A.C., Kijlstra A. Endotoxin-induced uveitis in the rat: the significance of intraocular interleukin 6. Invest. Ophthalmol. Vis. Sci. 1992; 33: 532–539
   PubMed Web of Science ®Google Scholar
• Murray P. I., Hoekzema R., Van Haren M. A.C, De Hon F. D., Kijlstra A. Aqueous humor interleukin-6 levels in uveitis. Invest. Ophthalmol. Vis. Sci. 1990; 31: 917–920
   PubMed Web of Science ®Google Scholar
• Van Der Lelij A., Rothova A., De Vries J. P., Vetter J. C.M., Van Haren M. A.C, Stilma J. S., Kijlstra A. Analysis of aqueous humour in ocular onchcerciasis. Curr. Eye Res. 1991; 10: 169–176
   PubMed Web of Science ®Google Scholar
• Baggiolini M., Walz A., Kunkel S. L. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest. 1989; 84: 1045–1049
   PubMed Web of Science ®Google Scholar
• Wolpe S. D., Cerami A. Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines. FASEB J. 1989; 3: 2565–2573
   PubMed Web of Science ®Google Scholar
• Elner V. M., Strieter R. M., Elner S. G., Baggiolini M., Lindley I., Kunkel S. L. Neutrophil chemotactic factor (IL-8) gene expression by cytokine-treated retinal pigment epithelial cells. Am. J. Pathol. 1990; 136: 745–750
   PubMed Web of Science ®Google Scholar
• Elner V. M., Strieter R. M., Pavilack M. A., Elner S. G., Remick D. G., Danforth J. M., Kunkel S. L. Human corneal interleukin-8: IL-1 and TNF-induced gene expression and secretion. Am. J. Pathol 1991; 139: 977–988
   PubMed Web of Science ®Google Scholar
• Ferrick M. R., Oppenheim M. H., Thurau S. R., Herbort C. R., Zachariae C. O.C., Chan C. C., Matsushima K. Ocular inflammation stimulated by intravitreal injection of interleukin-8. “Ocular Immunology Today”, M. Usui, S. Ohno, K. Aoki. Exerpta Medica, AmsterdamNetherlands 1990; 61–64
   Google Scholar
• Dawson M. M. Interferon-γ. “Lymphokines and Interleukins”, M. M. Dawson. Open University Press, BuckinghamEngland 1991; 190–210
   Google Scholar
• Hamel C. P., Detrick B., Hooks J. J. Evaluation of la expression in rat ocular tissues following inoculation with interferon-gamma. Exp. Eye Res. 1990; 50: 173–182
   PubMed Web of Science ®Google Scholar
• Lee S. F., Pepose J. S. Cellular immune response to la induction by intraocular gamma-interferon. Ophthalmic Res. 1990; 22: 310–317
   PubMedGoogle Scholar
• Kusuda M., Gaspari A. A., Chan C. C., Gery I., Katz S. Expression of la antigen by ocular tissues of mice treated with interferon gamma. Invest. Ophthalmol. Vis. Sci. 1989; 30: 764–768
   PubMedGoogle Scholar
• Abi-Hanna D., McCluskey P., Wakefield D. HLA antigens in the iris and aqueous humor gamma interferon levels in anterior uveitis. Invest. Ophthalmol. Vis. Sci. 1989; 30: 990–994
   PubMed Web of Science ®Google Scholar
• McAvoy J. W., Chamberlain C. G. Growth factors in the eye. Prog. Growth Factor Res. 1990; 2: 29–43
   PubMedGoogle Scholar
• Gospodarowicz D., Neufeld G., Schweigerer L. Fibroblast growth factor. Mol. Cell. Endocrinol. 1986; 46: 187–204
   PubMed Web of Science ®Google Scholar
• Schweigerer L., Ferrara N., Haaparanta T., Neufeld G., Gospodarowicz D. Basic fibroblast growth factor: expression in cultured cells derived from corneal endothelium and lens epithelium. Exp. Eye Res. 1988; 46: 71–80
   PubMed Web of Science ®Google Scholar
• Plouet J., Gospodarowicz D. Iris-derived melanocytes contain a growth factor that resembles basic fibroblast growth factor. Exp. Eye Res. 1990; 51: 519–529
   PubMed Web of Science ®Google Scholar
• Caruelle D., Groux-Muscatelli B., Gaudric A., Sestier C., Coscas G., Caruelle J. P., Barritault D. Immunological study of acidic fibroblast growth factor (aFGF) distribution in the eye. J. Cell. Biochem. 1989; 39: 117–128
   PubMed Web of Science ®Google Scholar
• Baudouin C., Fredj-Reygrobellet D., Caruelle J. P., Barritault D., Gastaud P., Lapalus P. Acidic fibroblast growth factor distribution in normal human eye and possible implications in ocular pathogenesis. Ophthalmic Res. 1990; 22: 73–81
   PubMed Web of Science ®Google Scholar
• Tripathi R. C., Millard C. B., Tripathi B. J., Reddy V. A molecule resembling fibroblast growth factor in aqueous humor. Am. J. Ophthalmol. 1988; 106: 230–231
   PubMed Web of Science ®Google Scholar
• Tripathi R. C., Millard C. B., Tripathi B. J. Protein composition of human aqueous humor: SDS-PAGE analysis of surgical and post-mortem samples. Exp. Eye Res. 1989; 48: 117–130
   PubMed Web of Science ®Google Scholar
• Tripathi R. C., Millard C. B., Tripathi B. J., Chailerborisuth N. S., Neely K. A., Ernest J. T. Aqueous humor of cat contains fibroblast growth factor and transferrin similar to those in man. Exp. Eye Res. 1990; 50: 109–112
   Google Scholar
• Tripathi R. C., Borisuth S. C., Tripathi B. J. Growth factors in the aqueous humor and their therapeutic implications in glaucoma and anterior segment disorders of the human eye. Drug Dev. Res. 1991; 22: 1–23
   Web of Science ®Google Scholar
• Folkman J., Klagsbrun M., Sasse J., Wadzinski M., Ingber D., Vlodavsky I. A heparin-binding angiogenic protein–basic fibroblast growth factor–is stored within basement membrane. Am. J. Pathol. 1988; 130: 393–400
   PubMed Web of Science ®Google Scholar
• Hanneken A., De Juan E., Lutty G. A., Fox G. M., Schiffer S., Hjelmeland L. M. Altered distribution of basic fibroblast growth factor in diabetic retinopathy. Arch. Ophthalmol. 1991; 109: 1005–1011
   PubMedGoogle Scholar
• Baird A., Culler F., Jones K. L., Guillemin R. Angiogenic factor in human ocular fluid. Lancet 1985; 11: 563
   Google Scholar
• Sivalingam A., Kenney J., Brown G. C., Benson W. E., Donoso L. Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch. Ophthalmol. 1990; 108: 869–872
   PubMed Web of Science ®Google Scholar
• Nilsen-Hamilton M. Transforming growth factor-β and its actions on cellular growth and differentiation. “Growth Factors and Development”, Current Topics in Developmental Biology 24, M. Nilsen-Hamilton. Academic Press Inc., San Diego, CA USA 1990; 95–136
   Google Scholar
• Wahl S. M., Cartney-Francis N., Mergenhagen S. E. Inflammatory and immunomodulatory roles of TGF-β. Immunol. Today 1989; 10: 258–261
   PubMedGoogle Scholar
• Miller A., Lider O., Roberts A. B., Sporn M. B., Weiner H. L. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen-specific triggering. Proc. Natl. Acad. Sci. USA 1992; 89: 421–425
   PubMed Web of Science ®Google Scholar
• Helbig H., Kittredge K. L., Coca-Prados M., Davis J., Palestin A. G., Nussenblatt R. B. Mammalian ciliary-body epithelial cells in culture produce transforming growth factor-beta. Greafe's Arch. Clin. Exp. Ophthalmol. 1991; 229: 84–87
   Google Scholar
• Knisely T. L., Bleicher P. A., Vibbard C. A., Granstein R. D. Production of latent transforming growth factor-beta and other inhibitory factors by cultured murine iris and ciliary body cells. Curr. Eye Res. 1991; 10: 761–771
   PubMed Web of Science ®Google Scholar
• Jampel H. D., Roche N., Stark W. J., Roberts A. B. Transforming growth factor-β in human aqueous humor. Curr. Eye Res. 1990; 2: 963–969
   Google Scholar
• Granstein R. D., Staszewski R., Knisely E. Z., Zeira E., Nazareno R., Latina M., Albert D. M. Aqueous humor contains transforming growth factor-β and a small (& lt3500 daltons) inhibitor of thymocyte proliferation. J. Immunol. 1990; 144: 3021–3027
   PubMed Web of Science ®Google Scholar
• Cousins S. W., McCabe M. M., Danielpour D., Streilein J. W. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest. Ophthalmol. Vis. Sci. 1991; 32: 2201–2211
   PubMed Web of Science ®Google Scholar
• Connor T. B., Roberts A. B., Sporn M. B., Dart L. L., Michels R. G., De Bustros S., Enger C., Kato H., Lansing M., Hayashi H., Glaser B. M. Correlation of fibrosis and transforming growth factor-β type 2 levels in the eye. J. Clin. Invest. 1989; 82: 1661–1666
   Google Scholar
• Yoshitoshi T., Shichi H. Immunosuppressive factors in porcine vitreous body. Curr. Eye Res. 1991; 10: 1141–1149
   PubMed Web of Science ®Google Scholar
• Lutty G., Ikeda K., Chandler C., McLeod D. S. Immunohistochemical localization of transforming growth factor-β in human photoreceptors. Curr. Eye Res. 1991; 10: 61–74
   PubMed Web of Science ®Google Scholar
• Hayashi K., Frangieh G., Wolf G., Kenyon K. R. Expression of transforming growth factor-β in wound healing of vitamin A-deficient rat corneas. Invest. Ophthalmol. Vis. Sci. 1989; 30: 239–247
   PubMed Web of Science ®Google Scholar
• Ferguson T. A., Mahendra S. The role of interleukin-4 and transforming growth factor-β in anterior chamber associated immune deviation (ACAID). Invest. Ophthalmol. Vis. Sci. 1991; 32: 1118, supply
   Google Scholar
• Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the newborn animal. J. Biol. Chem. 1962; 237: 1555–1562
   PubMed Web of Science ®Google Scholar
• Burgess A. W. Epidermal growth factor and transforming growth factor a. Br. Med. Bull. 1989; 45: 401–424
   PubMed Web of Science ®Google Scholar
• Lakshmanan J., Perheentupa J., Hoath S. B., Kim H., Gruters A., Odell C., Fisher D. A. Epidermal growth factor in mouse ocular tissue: effects of thyroxine and exogenous epidermal growth factor. Pediatr. Res. 1985; 19: 315–319
   Google Scholar
• Tripathi R. C., Borisuth N. S.C., Tripathi B. J., Fang V. S. Analysis of human aqueous humor for epidermal growth factor. Exp. Eye Res. 1991; 53: 407–409
   PubMed Web of Science ®Google Scholar
• Ohashi Y., Motokura M., Kinoshita Y., Mano T., Watanabe H., Kinoshita S., Manabe R., Oshiden K., Yanaihara C. Presence of epidermal growth factor in human tears. Invest. Ophthalmol. Vis. Sci. 1989; 30: 1879–1882
   PubMed Web of Science ®Google Scholar
• Parelman J. J., Nicolson M., Pepose J. S. Epidermal growth factor in human aqueous humor. Am. J. Ophthalmol. 1990; 109: 603–604
   PubMed Web of Science ®Google Scholar
• Shinoda I., Tokida N., Kurobe M., Furukawa S., Hayashi K. Demonstration of a considerable amount of mouse epidermal growth factor in aqueous humor. Biochem. Int. 1988; 17: 243–248
   Google Scholar
• Zapf J., Schmid C., Froesch E. R. Biological and immunological properties of insuline-like growth factors (IGF) I and II. Clin. Endocrinol. Met. 1984; 13: 3–30
   PubMedGoogle Scholar
• Grant M., Russell B., Fitzgerald C., Merimee T. J. Insulin-like growth factors in vitreous: studies in control and diabetic subjects with neovascularization. Diabetes 1986; 35: 416–420
   PubMed Web of Science ®Google Scholar
• Beebe D. C., Feagans D. E., Jebens H. A.H. Lentropin: a factor in vitreous humor which promotes lens fiber cell differentiation. Proc. Natl. Acad. Sci. USA 1980; 77: 490–493
   PubMed Web of Science ®Google Scholar
• Beebe D. C., Silver M. H., Belcher K. S., Van Wyk J. J., Svoboda M. E., Zelenka P. S. Lentropin, a protein that controles lens fiber formation, is related functionally and immunologically to the insulin-like growth factors. Proc. Natl. Acad. Sci. USA 1987; 84: 2327–2330
   PubMed Web of Science ®Google Scholar
• Danias J., Stylianopoulou F. Expression of IGF-I and IGF-II genes in the adult rat eye. Curr. Eye Res. 1990; 2: 379–386
   Google Scholar
• Hansson H. A., Holmgren A., Norstedt G., Rozell B. Changes in the distribution of insulin-like growth factor I, thioredoxin, thioredoxin reductase and ribonucleotide reductase during the development of the retina. Exp. Eye Res. 1989; 48: 411–420
   PubMedGoogle Scholar
• Kim M. K., Chan C. C., Nussenblatt R. B., Palestine A. G. Pharmacologic effects of class II histocompatibility antigen in experimental endotoxin-induced uveitis. Clin. Immunol. Immunopath. 1987; 45: 70–77
   PubMedGoogle Scholar
• Herbort C. P., Okumara A., Mochizuki M. Immunopharmacological analysis of endotoxin-induced uveitis in the rat. Exp. Eye Res. 1989; 48: 693–705
   PubMed Web of Science ®Google Scholar
• Lin N., Bazan H. E.P., Braquet P., Bazan N. G. Prolonged effect of a new platelet-activating factor antagonist on vascular permeability in an endotoxin model of uveitis. Curr. Eye Res. 1991; 10: 19–24
   PubMed Web of Science ®Google Scholar
• Tilden M. E., Boney R. S., Goldenberg M. M., Rosenbaum J. T. The effect of topical S(+)-ibuprofen on interleukin-1 induced ocular inflammation in a rabbit model. J. Ocul. Pharm. 1990; 6: 131–135
   Google Scholar
• Mochizuki M., Nussenblatt R. B., Kuwabara T., Gery I. Effects of cyclosporin and other immunosuppressive drugs on experimental autoimmune uveoretinitis in rats. Invest. Ophthalmol. Vis. Sci. 1985; 26: 226–232
   PubMed Web of Science ®Google Scholar
• Chan C. C., Ni M., Miele L., Cordella-Miele E., Ferrick M., Mukherjee A. B., Nussenblatt R. B. Effects of antiflammins on endotoxin-induced uveitis in rats. Arch. Ophthalmol. 1991; 109: 278–281
   PubMedGoogle Scholar
• Lightman S. Uveitis: management. Lancet 1991; 338: 1501–1504
   PubMed Web of Science ®Google Scholar
• Kijlstra A., Hoekzema R., Van Der Lelij A., Doekes G., Rothova A. Humoral and cellular immune reactions against retinal antigens in clinical disease. Curr. Eye Res. 1990; 9: 85–89, Supply
   PubMed Web of Science ®Google Scholar
• Herman D. C., Suffredini A. F., Parillo J. E., Palestine A. G. Ocular permeability after systemic administration of endotoxin in humans. Curr. Eye Res. 1991; 10: 121–126
   PubMed Web of Science ®Google Scholar
• Dinarello C. A., Thompson R. C. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol. Today 1991; 12: 404–410
   PubMedGoogle Scholar
• Rosenbaum J. T., Boney R. S. Activity of an interleukin-1 receptor antagonist in rabbit models of uveitis. Invest. Ophthalmol. Vis. Sci. 1991; 32: 1186, Suppl
   Google Scholar
• Rosenbaum J. T., Boney R. S. Use of a soluble interleukin-1 receptor to inhibit ocular inflammation. Curr. Eye Res. 1991; 10: 1137–1139
   PubMed Web of Science ®Google Scholar
• Lorberboum-Galski H., FitzGerald D., Chaudhary V., Adhya S., Pastan I. Cytotoxic activity of an interleukin 2-Pseudomonas exotoxin chimeric protein produced in Escherichia coli. Proc. Natl. Acad. Sci. USA 1988; 85: 1922–1926
   PubMed Web of Science ®Google Scholar
• Roberge F. G., Lorberboum-Galski H., Hoang P. L., De Smet M., Chan C. C., Fitzgerald D., Pastan I. Selective immunosuppression of activated T cells with the chimeric toxin IL-2-PE40: inhibition of experimental autoimmune uveoretinitis. J. Immunol. 1989; 142: 3498–3502
   Google Scholar
• Ogata M., Chaudhary V. K., FitzGerald D. J., Pastan I. Cytotoxic activity of a recombinant fusion protein between interleukin 4 and Pseudomonas exotoxin. Proc. Natl. Acad. Sci. USA 1989; 86: 4215–4219
   PubMedGoogle Scholar
• Siegall C. B., Nordan R. P., FitzGerald D. J., Pastan I. Cell-specific toxicity of a chimeric protein composed of interleukin-6 and Pseudomonas exotoxin (IL-6-PE40) on tumor cells. Mol. Cell. Biol. 1990; 10: 2443–2447
   PubMed Web of Science ®Google Scholar
• Chaudhary V. K., FitzGerald D. J., Adhaya S., Pastan I. Activity of a recombinant fusion protein between transforming growth factor type a and Pseudomonas toxin. Proc. Natl. Acad. Sci. USA 1987; 84: 4538–4543
   PubMed Web of Science ®Google Scholar
• Hess A. D., Colombani P. M. Mechanisms of action: in vitro studies. “Ciclosporin”, Prog. Allergy 2S, K. Ishizaka, P. J. Lachmann, P. Kallos, B. H. Waksman. Karger, BaselSwitzerland 1986; 198–221
   Google Scholar
• De Vries J., Baarsma G. S., Zaal M. J.W., Boen-Tan T. N., Rothova A., Buitenhuis H. J., Schweitzer C. M.C., De Keizer R. J.W., Kijlstra A. Cyclosporin in the treatment of severe chronic idiopathic uveitis. Br. J. Ophthalmol. 1990; 74: 344–349
   PubMed Web of Science ®Google Scholar
• Morris R. E. Rapamycin: FK506′s fraternal twin or distant cousin. Immunol. Today 1991; 12: 137–140
   PubMedGoogle Scholar
• Kawashima H., Fujino Y., Mochizuki M. Effects of a new immunosuppressive agent, FK506, on experimental autoimmune uveoretinitis in rats. Invest. Ophthalmol. Vis. Sci. 1988; 29: 1265–1271
   PubMed Web of Science ®Google Scholar
• Zabel P., Schonharting M. M., Wolter D. T., Schade U. F. Oxpentifylline in endotoxaemia. Lancet 1989; 11: 1474–1477
   Google Scholar
• Waage A., Sorensen M., Stordal B. Differential effect of oxpentifylline on tumour necrosis factor and interleukin-6 production. Lancet 1989; 335: 543
   Google Scholar